These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 11192920)
1. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile? Yildirim E; Celen O; Berberoglu U J Am Coll Surg; 2001 Jan; 192(1):25-37. PubMed ID: 11192920 [TBL] [Abstract][Full Text] [Related]
2. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma. Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772 [TBL] [Abstract][Full Text] [Related]
4. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients]. Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302 [TBL] [Abstract][Full Text] [Related]
5. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center. Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767 [TBL] [Abstract][Full Text] [Related]
6. Resection for gastric cancer in the community. van de Velde CJ Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441 [TBL] [Abstract][Full Text] [Related]
7. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer]. Lu W; Zeng X; Li N; Liu H Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512 [TBL] [Abstract][Full Text] [Related]
8. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes. Volpe CM; Driscoll DL; Douglass HO Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793 [TBL] [Abstract][Full Text] [Related]
9. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions. Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814 [TBL] [Abstract][Full Text] [Related]
10. Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for ≥ pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching. Kang JH; Ryu SY; Jung MR; Jeong O Eur J Surg Oncol; 2020 Jul; 46(7):1239-1246. PubMed ID: 32331983 [TBL] [Abstract][Full Text] [Related]
11. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?]. Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920 [TBL] [Abstract][Full Text] [Related]
12. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M; Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296 [TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification. Roukos D; Schmidt-Mathiesen A; Encke A Surg Oncol; 1995; 4(6):323-32. PubMed ID: 8809955 [TBL] [Abstract][Full Text] [Related]
14. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial. Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843 [TBL] [Abstract][Full Text] [Related]
16. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer. Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148 [TBL] [Abstract][Full Text] [Related]
17. D2 Lymphadenectomy for Gastric Adenocarcinoma: Long-term Results and the Impact of Surgeon Experience on the Survival Rates. Tudor S; Dumitrascu T; Manuc M; Trandafir B; Ionescu M; Popescu I; Herlea V; Vasilescu C Chirurgia (Bucur); 2018; 113(6):772-779. PubMed ID: 30596365 [No Abstract] [Full Text] [Related]
18. [Prognostic factors of lymph node-negative metastasis gastric cancer]. Sun D; Xu H; Huang J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354 [TBL] [Abstract][Full Text] [Related]
19. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Degiuli M; Sasako M; Ponti A; Calvo F Br J Cancer; 2004 May; 90(9):1727-32. PubMed ID: 15150592 [TBL] [Abstract][Full Text] [Related]
20. Lymph node metastasis with adenocarcinoma of the gastric cardia: clinicopathological analysis and indication for D1 dissection. Shimada H; Suzuki T; Nakajima K; Hori S; Hayashi H; Takeda A; Arima M; Gunji Y; Koide Y; Ochiai T Int Surg; 1999; 84(1):13-7. PubMed ID: 10421011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]